Электронный архив

Просмотр Научные публикации в Scopus по автору "Nasyrova R.F."

Просмотр Научные публикации в Scopus по автору "Nasyrova R.F."

Отсортировать по:Сортировать:Результаты поиска на странице:

  • Nasyrova R.F.; Moskaleva P.V.; Vaiman E.E.; Shnayder N.A.; Blatt N.L.; Rizvanov A.A. (2020)
    © 2020 by the authors. Licensee MDPI, Basel, Switzerland. T. According to the recent data, nitric oxide (NO) is a chemical messenger that mediates functions such as vasodilation and neurotransmission, as well as displaying ...
  • Savinova A.V.; Shnayder N.A.; Nasyrova R.F. (2021)
    Aim. To analyze results of the studies covering modern scientific views on the genetics of familial amyotrophic lateral sclerosis (FALS). Materials and methods. We searched for full-text publications containing the key ...
  • Savinova A.V.; Petrova M.M.; Shnayder N.A.; Bochanova E.N.; Nasyrova R.F. (2020)
    © 2020 Stolichnaya Izdatelskaya Kompaniya. All rights reserved. Apixaban is oral anticoagulant, it is widely used in prevention of stroke in non-valvular atrial fibrillation and treatment of deep vein thrombosis and pulmonary ...
  • Savinova A.V.; Dobrodeeva V.S.; Petrova M.M.; Nasyrova R.F.; Shnayder N.A. (2021)
    Dabigatran etexilate is a prodrug of dabigatran, a oral direct inhibitor of thrombin. Pharmacokinetics of dabigatran etexilate doesn't have the disadvantages of vitamin K antagonists. However, pharmacokinetics and ...
  • Borzykh O.B.; Petrova M.M.; Shnayder N.A.; Nasyrova R.F. (2021)
    At the present time, the 4P concept (predictive, preventive, personalised and participatory) is a prospective trend in development of clinical medi-cine. The concept is being actively introduced into different medical ...

Поиск в электронном архиве


Расширенный поиск

Просмотр

Моя учетная запись